Pine River Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Pine River Capital Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-12,400	Closed	-$501K	–	699
2015 Q3	$501K	Buy	12,400 +3,700	+43%	+$192K	0.01%	523
2015 Q2	$501K	Buy	+8,700	New	+$553K	0.01%	523
2015 Q1	–	Sell	-17,866	Closed	-$1.1M	–	704
2014 Q4	$1.1M	Buy	+17,866	New	+$882K	0.01%	506
2014 Q3	–	Sell	-14,872	Closed	-$512K	–	1007
2014 Q2	$512K	Buy	+14,872	New	+$468K	0.01%	594

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Pine River Capital Management's IONS Position: Q4 2015 in Review

Pine River Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q4 2015, closing a stake of 12,400 shares — an estimated $501K sold.

Pine River Capital Management first reported a position in IONS in Q2 2014 and held it in 4 quarters. The position peaked at $1.1M in Q4 2014. 334 funds tracked by Wall St. Rank hold IONS as of Q4 2015.

Pine River Capital Management reported no remaining Ionis Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
Pine River Capital Management sold 12,400 Ionis Pharmaceuticals shares in Q4 2015, an estimated $501K.
Pine River Capital Management first reported a position in Ionis Pharmaceuticals in Q2 2014 and held it in 4 quarters.
Pine River Capital Management's Ionis Pharmaceuticals position peaked at $1.1M in Q4 2014.
334 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2015.

Based on Pine River Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.